Drugs Online |
 |
 | ||
|
Duphaston (Dydrogesterone) |
|
| ||
Drugs Online » Women's Health » Duphaston (Dydrogesterone) Duphaston (Dydrogesterone) is an orally active progestogen which acts directly on the uterus producing a complete secretory endometrium in an estrogen-primed uterus.At therapeutic levels dydrogesterone has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum. Furthermore Duphaston is non-androgenic non-estrogenic non-corticoid non-anabolic and is not excreted as pregnanediol. Buy Duphaston (Dydrogesterone) and other Women's Health products online at Medstore. Buy Online at Medstore - Click Here!
About Duphaston (Dydrogesterone): Product Type: Women's Health Brand name: Duphaston Generic name: Dydrogesterone Common uses Duphaston is an orally active progestogen which acts directly on the uterus producing a complete secretory endometrium in an estrogen-primed uterus. At therapeutic levels Duphaston has no contraceptive effect as it does not inhibit or interfere with ovulation or the corpus luteum. Furthermore Duphaston is non-androgenic non-estrogenic non-corticoid non-anabolic and is not excreted as pregnanediol. Before using Irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Combined with an estrogenic substance Duphaston can be applied in secondary amenorrhoea dysfunctional uterine bleeding and post-menopausal complaints where endogenous progesterone deficiency is implicated. Directions In general The dosage schemes below are meant as general recommendations. For optimal therapeutic effect the dosages are to be adapted to the nature and severity of the disorder. In irregular cycles due to endogenous progesterone deficiency Duphaston 5 to 10 mg is recommended especially in irregular cycles due to shortened luteal phase (ie pre-menopause). Treatment should be repeated for several cycles. In secondary amenorrhoea Administration of Duphaston in combination with an estrogen is usually recommended as in these conditions endogenous progesterone deficiency is nearly always accompanied by estrogen deficiency. 0 05 mg ethinylestradiol is administered each day from the 1st to the 25th day of the cycle and 5 mg Duphaston is added twice daily from the 11th to the 25th day. Five days after the subsequent withdrawal bleeding the same is repeated to imitate a natural cycle. In dysfunctional uterine bleeding The symptomatic treatment is aimed at stopping the bleeding and including a subsequent withdrawal bleeding. To stop bleeding: Duphaston 10 mg together with 0 10 mg ethinylestradiol twice daily for 5 to 7 days. To prevent heavy bleedings: Duphaston 5 mg twice daily from day 11 to day 25 of the cycle if necessary combined with an estrogen during the first half of the cycle. In post-menopausal complaints If for the symptomatic treatment of post-menopausal complaints estrogens are used (hormone replacement therapy — HRT) Duphaston 10 mg is used to counteract the effects of unopposed estrogens on the endometrium. A subsequent withdrawal bleeding is induced. If on continuous estrogen therapy: Duphaston 10 mg twice daily during the first 12 to 14 days of each calendar month. If on cyclic estrogen therapy: Duphaston 10 mg twice daily during the last 12 to 14 days of the treatment. Cautions Duphaston should not be given to patients with undiagnosed vaginal bleeding nor to those with a history of thromboembolic disorders. Duphaston should be used with caution in patients with cardiovascular renal or hepatic impairment diabetes mellitus asthma epilepsy and migraine. It should be used with care in persons with a history of mental depression. Store in a dry dark place at temperatures not exceeding 25°C. Keep out of reach of children. Possible side effects Side effects of Duphaston may include gastro-intestinal disturbances allergic skin rashes or urticaria changes in libido acne fluid retention mass gain mental depression and breast changes which may include discomfort or gynaecomastia. Alterations in liver function tests have been reported and less frequently jaundice. In a small percentage of the treated cases breakthrough bleeding may occur which can be prevented by increasing the dosage. During the clinical application of Duphaston no virilising side effects were observed. If you take too much See "Possible side effects" and "Cautions". Treatment is symptomatic and supportive. Drug interactions Drug interactions can result in unwanted side effects or prevent a medicine from doing its job. Some medicines or medical conditions may interact with this medicine. Inform your doctor or pharmacist of all prescription and over-the-counter medicine that you are taking. Generic Duphaston (Dydrogesterone) Diphaston Dufaston Duvaron Dydrogesterona Gestatron Gynorest Hydrogesterone Isopregnenone Prodel Retrone Terolut 10mg 100 pills 10mg 20 pills 10mg 40 pills 10mg 30 pills 10mg 50 pills Dydrogesterone Duphaston
View more Women's Health Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
